We narrowed to 165 results for: CAG

1. pAAV-CAG-eYFP (AAV Retrograde)

   Viral Prep

   #104055-AAVrg

   Purpose

   Ready-to-use AAV Retrograde particles produced from pAAV-CAG-eYFP (#104055). In addition to the viral particles, you will also receive purified pAAV-CAG-eYFP plasmid DNA. CAG-driven eYFP expression control. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

   Promoter

   CAG

   Tags

   EYFP

   Available Since

   Jan. 6, 2022

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-CAG-eYFP (AAV PHP.eB)

   Viral Prep

   #104055-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from pAAV-CAG-eYFP (#104055). In addition to the viral particles, you will also receive purified pAAV-CAG-eYFP plasmid DNA. CAG-driven eYFP expression control. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Challis et al Nat Protoc. 2019 Feb;14(2):379-414. doi:

   Promoter

   CAG

   Tags

   EYFP

   Available Since

   June 13, 2023

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-CAG-GFP (AAV8 trial size)

   Viral Prep

   #37825-AAV8.T

   Purpose

   Ready-to-use AAV8 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available Since

   May 29, 2019

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-CAG-GFP (AAV9 trial size)

   Viral Prep

   #37825-AAV9.T

   Purpose

   Ready-to-use AAV9 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available Since

   May 29, 2019

   Availability

   Academic Institutions and Nonprofits only

5. pAAV-CAG-GFP (AAV1 trial size)

   Viral Prep

   #37825-AAV1.T

   Purpose

   Ready-to-use AAV1 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available Since

   May 29, 2019

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-CAG-GFP (AAV6 trial size)

   Viral Prep

   #37825-AAV6.T

   Purpose

   Ready-to-use AAV6 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available Since

   July 16, 2025

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-CAG-NIR-GECO2G (AAV1)

   Viral Prep

   #159605-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-CAG-NIR-GECO2G (#159605). In addition to the viral particles, you will also receive purified pAAV-CAG-NIR-GECO2G plasmid DNA. CAG-driven expression of the near-infrared calcium indicator NIR-GECO2G. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Robert Campbell

   Article

   Qian et al PLoS Biol. 2020 Nov 24;18(11):e3000965.

   Promoter

   CAG

   Available Since

   Dec. 18, 2024

   Availability

   Academic Institutions and Nonprofits only

8. pAAV-CAG-GFP (AAV2 trial size)

   Viral Prep

   #37825-AAV2.T

   Purpose

   Ready-to-use AAV2 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Promoter

   CAG

   Tags

   GFP

   Available Since

   May 29, 2019

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-CAG-FLEX-EGFP (AAV1)

   Viral Prep

   #59331-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-CAG-FLEX-EGFP (#59331). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEX-EGFP plasmid DNA. CAG-driven, Cre-dependent expression of EGFP. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Ian Wickersham

   Promoter

   CAG

   Tags

   EGFP

   Available Since

   July 12, 2023

   Availability

   Academic Institutions and Nonprofits only

10. pACAGW-ChR2-Venus-AAV (AAV9)

    Viral Prep

    #20071-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pACAGW-ChR2-Venus-AAV (#20071). In addition to the viral particles, you will also receive purified pACAGW-ChR2-Venus-AAV plasmid DNA. CAG-driven, channelrhodopsin fused to Venus for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karel Svoboda

    Article

    Leopoldo et al Nature. 2009 Jan 18.

    Promoter

    CAGG

    Tags

    Venus

    Available Since

    March 15, 2018

    Availability

    Academic Institutions and Nonprofits only

11. pAAV-CAG-NIR-GECO2G (AAV2)

    Viral Prep

    #159605-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pAAV-CAG-NIR-GECO2G (#159605). In addition to the viral particles, you will also receive purified pAAV-CAG-NIR-GECO2G plasmid DNA. CAG-driven expression of the near-infrared calcium indicator NIR-GECO2G. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Robert Campbell

    Article

    Qian et al PLoS Biol. 2020 Nov 24;18(11):e3000965.

    Promoter

    CAG

    Available Since

    Dec. 18, 2024

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-CAG-FLEx-iSeroSnFR (AAV9)

    Viral Prep

    #128486-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-CAG-FLEx-iSeroSnFR (#128486). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEx-iSeroSnFR plasmid DNA. CAG driven, Cre-dependent expression of iSeroSnFR. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Lin Tian

    Article

    Unger et al Cell. 2020 Dec 12. pii: S0092-8674(20)31

    Promoter

    CAG

    Available Since

    Sept. 27, 2024

    Availability

    Academic Institutions and Nonprofits only

13. pAAV.CAGFLEX.(cyto).iATPSnFR2.S29W.A95K.HaloTag (AAV5)

    Viral Prep

    #209655-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV.CAGFLEX.(cyto).iATPSnFR2.S29W.A95K.HaloTag (#209655). In addition to the viral particles, you will also receive purified pAAV.CAGFLEX.(cyto).iATPSnFR2.S29W.A95K.HaloTag plasmid DNA. CAG-driven, Cre-dependent expression of the high affinity ATP biosensor iATPSnFR2. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Tim Brown, HHMI-JRC Tool Translation Team

    Article

    Marvin et al Proc Natl Acad Sci U S A. 2024 May 21;12

    Promoter

    CAG

    Available Since

    Oct. 21, 2024

    Availability

    Academic Institutions and Nonprofits only

14. AAV-CAG-jGCaMP8s-WPRE (AAV9)

    Viral Prep

    #179256-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from AAV-CAG-jGCaMP8s-WPRE (#179256). In addition to the viral particles, you will also receive purified AAV-CAG-jGCaMP8s-WPRE plasmid DNA. CAG-driven expression of calcium sensor GCaMP8s. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Loren Looger

    Promoter

    CAG

    Available Since

    May 22, 2023

    Availability

    Academic Institutions and Nonprofits only

15. AAV-CAG-jGCaMP8s-WPRE (AAV1)

    Viral Prep

    #179256-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from AAV-CAG-jGCaMP8s-WPRE (#179256). In addition to the viral particles, you will also receive purified AAV-CAG-jGCaMP8s-WPRE plasmid DNA. CAG-driven expression of calcium sensor GCaMP8s. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Loren Looger

    Promoter

    CAG

    Available Since

    Jan. 24, 2024

    Availability

    Academic Institutions and Nonprofits only

16. pAAV-CAG-GFP (AAV CAP-B22)

    Viral Prep

    #37825-CAP-B22

    Purpose

    Ready-to-use AAV CAP-B22 particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV were produced with the CAP-B22 serotype, which permits efficient transduction of neurons and astrocytes in the central nervous system. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Promoter

    CAG

    Tags

    GFP

    Available Since

    Nov. 8, 2023

    Availability

    Academic Institutions and Nonprofits only

17. paavCAG-post-mGRASP-2A-dTomato (AAV5)

    Viral Prep

    #34912-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from paavCAG-post-mGRASP-2A-dTomato (#34912). In addition to the viral particles, you will also receive purified paavCAG-post-mGRASP-2A-dTomato plasmid DNA. CAG-driven expression of post-synaptic mGRASP-2A-dTomato for synaptic connectivity mapping. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jinhyun Kim

    Article

    Kim et al Nat Methods. 2011 Dec 4;9(1):96-102. doi

    Promoter

    CAG

    Tags

    dTomato

    Available Since

    Aug. 7, 2025

    Availability

    Academic Institutions and Nonprofits only

18. paavCAG-pre-mGRASP-mCerulean (AAV5)

    Viral Prep

    #34910-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from paavCAG-pre-mGRASP-mCerulean (#34910). In addition to the viral particles, you will also receive purified paavCAG-pre-mGRASP-mCerulean plasmid DNA. CAG-driven expression of presynaptic mGRASP-mCerulean for synaptic connectivity mapping. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jinhyun Kim

    Article

    Kim et al Nat Methods. 2011 Dec 4;9(1):96-102. doi

    Promoter

    CAG

    Tags

    mCerulean

    Available Since

    Aug. 7, 2025

    Availability

    Academic Institutions and Nonprofits only

19. AAV-CAG-jGCaMP8f-WPRE (AAV9)

    Viral Prep

    #179254-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from AAV-CAG-jGCaMP8f-WPRE (#179254). In addition to the viral particles, you will also receive purified AAV-CAG-jGCaMP8f-WPRE plasmid DNA. CAG-driven expression of calcium sensor GCaMP8f. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Loren Looger

    Promoter

    CAG

    Available Since

    May 19, 2023

    Availability

    Academic Institutions and Nonprofits only

20. pAAV-CAG-GFP (AAV5 trial size)

    Viral Prep

    #37825-AAV5.T

    Purpose

    Ready-to-use AAV5 trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Promoter

    CAG

    Tags

    GFP

    Available Since

    May 29, 2019

    Availability

    Academic Institutions and Nonprofits only